Sumatriptan in the treatment of migraine attacks

Abstract

In this article, some of the problems encountered in the treatment of migraine attacks are evaluated on the basis of the experiences with the novel 5-HT1 agonist sumatriptan. The high specificity of the mechanism of action and the early onset of efficacy are considered to be important factors of this drug. The phenomenon of headache recurrence is discussed, together with the problem of the cost of sumatriptan.